Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022
Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022

Anupam Rama Initiated (SNDX) at Buy and Held Target at $41 on, Jan 3rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-41-on-jan-3rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Anupam Rama of JP Morgan, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Buy and Held Target at $41 on, Jan 3rd, 2023.

Anupam has made no other calls on SNDX in the last 4 months.



There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Anupam


  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $33 on, Monday, December 12th, 2022
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $39 on, Monday, December 12th, 2022

Publication Contributing Sources